Palo Alto Investors’s Precigen PGEN Stock Holding History

Palo Alto Investors’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-41,900	Closed	-$830K	–	39
2017 Q1	$830K	Sell	41,900 -377	-0.9%	-$8.42K	0.04%	34
2016 Q4	$1.02M	Sell	42,277 -5,247	-11%	-$146K	0.06%	31
2016 Q3	$1.32M	Hold	47,524	–	–	0.08%	35
2016 Q2	$1.16M	Hold	47,524	–	–	0.09%	38
2016 Q1	$1.6M	Hold	47,524	–	–	0.12%	35
2015 Q4	$1.42M	Hold	47,524	–	–	0.08%	38
2015 Q3	$1.5M	Hold	47,524	–	–	0.07%	40
2015 Q2	$2.3M	Sell	47,524 -1,758	-4%	-$74.1K	0.1%	38
2015 Q1	$2.14M	Buy	49,282 +3,557	+8%	+$128K	0.11%	38
2014 Q4	$1.2M	Buy	+45,725	New	+$1M	0.07%	41

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Palo Alto Investors's PGEN Position: Q2 2017 in Review

Palo Alto Investors sold out of Precigen (PGEN) in Q2 2017, closing a stake of 41,900 shares — an estimated $830K sold.

Palo Alto Investors first reported a position in PGEN in Q4 2014 and held it in 10 quarters. The position peaked at $2.3M in Q2 2015. 172 funds tracked by Wall St. Rank hold PGEN as of Q2 2017.

Palo Alto Investors reported no remaining Precigen position as of Q2 2017 after selling out during the quarter.
Palo Alto Investors sold 41,900 Precigen shares in Q2 2017, an estimated $830K.
Palo Alto Investors first reported a position in Precigen in Q4 2014 and held it in 10 quarters.
Palo Alto Investors's Precigen position peaked at $2.3M in Q2 2015.
172 funds tracked by Wall St. Rank held Precigen as of Q2 2017.

Based on Palo Alto Investors's 13F filing for Q2 2017, filed 14 Aug 2017.